No items found.
Rx

Semaglutide

Achieve your weight-loss goals with our Semaglutide, produced by a US-licensed, certified pharmacy.

  • Appetite suppression
  • Weight loss of 10-15% of total body weight
  • Improve cardiovascular health
  • Blood sugar control
  • Anti-inflammatory effects

Semaglutide is designed to mimic a GLP-1, a hormone that we naturally produce when we eat to help control blood sugar levels. By mimicking this hormone, Semaglutide can help stimulate insulin production, suppress the release of glucagon, delay the rate at which your stomach empties & reduce your appetite.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Get started
Health & price guarantee
Health and price guarantee

The Superpower Research team promises top levels of ingredient quality and scientific efficacy, as well as better prices than anywhere else on the internet. We’ll price match anything you find lower.

The science of Semaglutide

Active ingredients

Semaglutide is the primary active ingredient, which is the same as in commercial products like Ozempic and Wegovy. It’s a GLP-1 receptor agonist used to manage blood sugar levels and promote weight loss. Additional excipients, stabilizers and solvents are added to help with absorption.

Mechanism

Semaglutide is usually administered through subcutaneous injection. The specific dosage will be determined by healthcare professionals based on individual needs. Strict adherence to the prescribed administration guidelines is crucial for optimal results.

History

Semaglutide is a relatively recent addition to the class of medications known as GLP-1 receptor agonists, which are used primarily for treating type 2 diabetes and, more recently, obesity. Semaglutide was developed by the Danish pharmaceutical company Novo Nordisk. It is based on the GLP-1 hormone, which helps regulate blood sugar levels and appetite. In December 2017, the U.S. Food and Drug Administration (FDA) approved semaglutide under the brand name Ozempic® for the treatment of type 2 diabetes.Recognizing the significant weight-loss benefits observed in clinical trials, Novo Nordisk pursued additional approval for semaglutide as a treatment for obesity, approved in June 2021 under the brand name Wegovy®.

How to get Semaglutide

Answer a few questions to confirm if this product is right for you.

Your Superpower clinical team (licensed physician) will review and approve.

We’ll ship it to you, and you can manage in your dashboard.

Get unlimited support through our Superpower Concierge.

Frequently Asked Questions

For Superpower Members, text your private concierge at any time with any question

Important Safety Information

For Superpower Members, text your private concierge at any time with any question